Thymosin beta 4 TB500 5mg vials explained: what the peptide is, how researchers reconstitute and store it, typical lab protocols, and safety limits.
Thymosin beta 4 TB500 5mg refers to a lyophilized vial that contains 5 milligrams of a synthetic 43-amino-acid peptide sold in the research market as TB-500. In the United States it is distributed as a laboratory research chemical, not as a drug: it is not FDA-approved for human use, and no controlled human data supports any medical claim about it. The 5 mg size is popular because it sits between the small 2 mg vials used for pilot work and the bulk 10 mg vials.
This guide covers what the peptide is, how a 5 mg vial is reconstituted and stored, what animal research has examined, and how much weight to give the claims you see online.
What Is Thymosin Beta 4 and Why Is It Called TB500?
Thymosin beta 4 is a naturally occurring protein found in nearly every cell type, with high concentrations in platelets and wound fluid. It binds actin, the protein that gives cells their shape, and it appears to be involved in cell migration, tissue repair, and blood vessel formation.
TB-500 is the name the research-peptide market uses for a synthetic version of the full 43-amino-acid sequence, sometimes shortened to a smaller active region. Vials labeled thymosin beta 4 tb500 5mg should contain a white or off-white lyophilized cake plus a certificate of analysis from a third-party lab, typically showing HPLC purity of 98% or higher.
What a 5 mg Vial Actually Gives You
Vial size tells you the mass of peptide, not the concentration in a pipette or syringe. Concentration depends entirely on how much solvent you add during reconstitution. Less water creates a stronger solution that is easier to measure in tiny volumes, but it also leaves less margin for measurement error.
| Vial size | Bacteriostatic water added | Resulting concentration | Research note |
|---|---|---|---|
| 2 mg | 1 mL | 2 mg/mL | Small pilot assays |
| 5 mg | 1 mL | 5 mg/mL | Standard; fewer vials per study |
| 5 mg | 2 mL | 2.5 mg/mL | Easier to measure small volumes |
| 10 mg | 2 mL | 5 mg/mL | Bulk work; aliquot to limit freeze-thaw cycles |
A 5 mg vial reconstituted with 1 mL gives 5 mg/mL, which means every 0.1 mL holds 0.5 mg of peptide. That simple math is the reason most labs standardize on one reconstitution volume per study and write it down.
Reconstitution and Storage Steps
- Let the vial reach room temperature before opening it, which reduces condensation on the powder.
- Swab the rubber stopper with an alcohol pad and let it dry completely.
- Aim the bacteriostatic water at the glass wall rather than directly at the powder.
- Swirl gently until the powder dissolves. Never shake a peptide vial.
- Store the reconstituted solution at 2-8 degrees Celsius, protected from light, and use it within a few weeks.
- Aliquot larger vials into single-use portions before freezing so the peptide does not go through repeated freeze-thaw cycles.
Unreconstituted powder is usually stored at -20 degrees Celsius for longer-term stability. A vial that arrives warm, clumped, or discolored should be treated as degraded rather than salvaged.
What Animal Research Has Examined
Most published data on this peptide comes from cell cultures and rodent models. Scientists have studied it for cell migration, corneal and skin wound closure, cardiac tissue repair after induced injury, and shifts in inflammatory markers.
Some of the most-cited papers describe thymosin beta 4 benefits in wound-healing models, where treated animals closed experimental skin wounds faster than controls. Those are animal results, and animal results often fail to carry over to people.
Rodent studies of thymosin beta 4 hair growth report faster follicle cycling and increased regrowth in some models. No well-controlled human trial has confirmed that effect, so hair regrowth claims in people remain unproven.
Animal and cell-culture findings are a starting point for research, not a treatment recommendation for humans.
Dosing Questions and Why the Numbers Are Hard to Trust
Because the peptide has no approved human indication, there is no established thymosin beta 4 dosage. Numbers that circulate on forums come from animal studies converted by body weight or from informal self-experimentation, and none of them come from controlled human trials.
A thymosin beta 4 injection is not an approved product in the United States. Anything marketed for injection is an unapproved research chemical, and sterility, identity, and exact concentration are not guaranteed by any regulator.
Many people comparing recovery-focused protocols read about BPC-157 alongside this peptide, since both appear in the same forum threads. They are different molecules with different mechanisms, and combining them does not create clinical evidence where none exists.
Purity, Vendors, and What Online Reviews Are Worth
Online thymosin beta 4 reviews are anecdotal, unverifiable, and frequently posted by accounts connected to the seller. They are not evidence of purity, and they cannot confirm that a vial contains the peptide printed on the label.
- Ask for a third-party certificate of analysis with a batch number that matches the vial in your hand.
- Look for HPLC purity results, mass spectrometry identity confirmation, and a recent testing date.
- Confirm the product is lyophilized powder unless the seller can document cold-chain shipping for a liquid.
- Be skeptical of wording such as 'pharmaceutical grade' or 'FDA approved' on a research product.
Purity matters more than price per milligram. A cheap 5 mg vial with no documentation is not a bargain if the identity or quantity of the contents is unknown.
Safety and Legal Status in the United States
Thymosin beta 4 is not FDA-approved for human use in the United States, and it is not a legal dietary supplement ingredient. Vials are sold 'for research use only,' which means they are not intended for human consumption and carry no dosing, sterility, or safety guarantees.
Reported side effects in the limited human data are mostly mild, including injection-site irritation, temporary redness, and headache. The data are far too thin to characterize risk, especially with repeated use or with stacking alongside other peptides.
If you are considering this peptide for a health condition, talk with a licensed healthcare professional instead of following a forum protocol. A clinician can walk you through approved options that have actually been tested in humans.
Frequently Asked Questions
What is a TB500 5mg vial used for?
A TB500 5mg vial is used in laboratory and animal research on cell migration, actin binding, and tissue repair. It is not FDA-approved for human use, and no controlled human trial has established a safe or effective dose. Any human use is unapproved and unsupported by clinical evidence.
How do you reconstitute a 5mg thymosin beta 4 vial?
Add 1 mL of bacteriostatic water for a 5 mg/mL solution, or 2 mL for 2.5 mg/mL. Aim the liquid at the vial wall, swirl gently, and never shake it. Store the reconstituted peptide at 2-8 degrees Celsius, protected from light, and use it within a few weeks.
Is TB500 the same as thymosin beta 4?
TB-500 is the research-market name for a synthetic version of the thymosin beta 4 sequence, so the two names are usually treated as interchangeable. It is not FDA-approved for human use in the United States and is sold only as a research chemical. Product purity and identity vary widely between vendors.
This page provides educational research information and does not replace medical advice, diagnosis, or treatment.